Off-Label Use of Medical Devices in Children.

نویسندگان

  • Michael G. Vitale
  • L. LuAnn Minich
  • Michael J. Ackerman
  • Stuart Berger
  • Robert Douglas Benjamin Jaquiss
  • Kathy J. Jenkins
  • William T. Mahle
  • Bradley S. Marino
  • Julie Anne Vincent
  • William R. Morrow
  • Vivian Thorne
  • Norman Y. Otsuka
  • Joshua M. Abzug
  • Theodore John Ganley
  • Martin Joseph Herman
  • Joshua E. Hyman
  • Lee S. Segal
  • Brian Anthony Shaw
  • Richard M. Schwend
  • S. Niccole Alexander
چکیده

Despite widespread therapeutic needs, the majority of medical and surgical devices used in children do not have approval or clearance from the Food and Drug Administration (FDA) for use in pediatric populations. The clinical need for devices to diagnose and treat diseases or conditions occurring in children has led to the widespread and necessary practice in pediatric medicine and surgery of using approved devices for "off-label" or "physician-directed" applications that are not included in FDA-approved labeling. This practice is common and often appropriate, even with the highest-risk (class III) devices. The legal and regulatory framework used by the FDA for devices is complex, and economic or market barriers to medical and surgical device development for children are significant. Given the need for pediatric medical and surgical devices and the challenges to pediatric device development, off-label use is a necessary and appropriate part of care. In addition, because of the relatively uncommon nature of pediatric conditions, FDA clearance or approval often requires other regulatory pathways (eg, Humanitarian Device Exemption), which can cause confusion among pediatricians and payers about whether a specific use, even of an approved device, is considered experimental. This policy statement describes the appropriateness of off-label use of devices in children; the use of devices approved or cleared through the FDA regulatory processes, including through the Humanitarian Device Exemption; and the important need to increase pediatric device labeling information for all devices and especially those that pose the highest risk to children.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Outcomes Associated with the Off-label Use of Medical Devices in Congenital Heart Disease at a Single Institute

BACKGROUND AND OBJECTIVES While the off-label use of implantable medical devices for treating congenital heart disease is not uncommon, the present conditions and outcomes of their off-label use have rarely been described. Therefore, this study evaluated the prevalence and results of using implantable devices off-label to treat congenital heart disease at a single institute. SUBJECTS AND METH...

متن کامل

Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.

BACKGROUND Many medications used for children have not undergone evaluation to assure acceptable standards for optimal dose, safety and efficacy. As a result, the majority of children admitted to hospital wards receive medications outside the terms of their license (off-label) or medications that are not specifically licensed for use in children (unlicensed). The extent of unlicensed and off-la...

متن کامل

When Are Medical Apps Medical? Off-Label Use and the Food and Drug Administration

People have a love/hate relationship with rapidly changing healthcare technology. While consumer demand for medical apps continues to grow as rapidly as does supply (there are over 100,000 health, wellness and medical applications, or ‘apps’ on the market), healthcare professionals and safety experts worry about the impact of these apps on the health consumer. In response to the rapidly growing...

متن کامل

Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children.

OBJECTIVE To determine the extent of use of unlicensed and off label drugs in children in hospital in five European countries. DESIGN Prospective study of drugs administered to children in general paediatric medical wards over four weeks. SETTING Children's wards in five hospitals (one each in the United Kingdom, Sweden, Germany, Italy, and the Netherlands). SUBJECTS Children aged 4 days ...

متن کامل

Unlicensed and off label drug use in paediatric wards: prospective study.

OBJECTIVE To determine the extent of use in children in hospital of drugs that are not specifically licensed for use in children (unlicensed) and of drugs that are used outside the terms of their product licence that apply to indication, age, dose, or route of administration (off label). DESIGN Prospective study of drugs administered on paediatric medical and surgical wards for 13 weeks. SE...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Pediatrics

دوره 139 1  شماره 

صفحات  -

تاریخ انتشار 2017